Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP

Journal of Neurochemistry

Volumn 83, Issue 1, 2002, Pages 37-47

  Wykes, Victoria ^a   Bellamy, Tomas C ^a,b   Garthwaite, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cyclic GMP; Nitric oxide; Phosphodiesterase; Soluble guanylyl cycase; Striatum

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; CEREBELLUM; CORPUS STRIATUM; HYDROLYSIS; KINETICS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL SEPARATION; COMPUTER SIMULATION; CORPUS STRIATUM; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEEDBACK, BIOCHEMICAL; GUANYLATE CYCLASE; KINETICS; MODELS, THEORETICAL; NEURONS; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036788270     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01106.x     Document Type: Article

References (48)

1. 2+/calmodulin-dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from rat cerebellum. Eur. J. Pharmacol. 323, 119-125.
2. Ahn H. S., Crim W., Romano M., Sybertz E. and Pitts B. (1989) Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem. Pharmacol. 38, 3331-3339.
3. Almeida A., Heales S. J., Bolanos J. P. and Medina J. M. (1998) Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790, 209-216.
4. Andreeva S. G., Dikkes P., Epstein P. M. and Rosenberg P. A. (2001) Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J. Neurosci. 21, 9068-9076.
5. Beavo J. A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
6. Bellamy T. C. and Garthwaite J. (2001a) Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 276, 4297-4292.
7. Bellamy T. C. and Garthwaite J. (2001b) 'cAMP-specific' phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Mol. Pharmacol. 59, 54-61.
8. Bellamy T. C., Wood J., Goodwin D. A. and Garthwaite J. (2000) Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl Acad. Sci. USA 97, 2928-2933.
9. Calabresi P., Gubellini P., Centonze D., Sancesario G., Morello M., Giorgi M., Pisani A. and Bemardi G. (1999) A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19, 2489-2499.
10. Centonze D., Pisani A., Bonsi P., Giacomini P., Bemardi G. and Calabresi P. (2001) Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic intemeurons via protein kinase G activation. J. Neurosci. 21, 1393-1400.
11. Chem Y. (2000) Regulation of adenylyl cyclase in the central nervous system. Cell. Signal. 12, 195-204.
12. Cherry J. A. and Davis R. L. (1999) Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J. Comp. Neurol. 407, 287-301.
13. Contestabile A. (2000) Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Rev. 32, 476-509.
14. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. USA 88, 6368-6371.
15. East S. J., Parry-Jones A. and Brotchie J. M. (1996) Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatum. Neuroreport 8, 71-75.
16. Femley H. N. (1974) Statistical estimations in enzyme kinetics. The integrated Michaelis equation. Eur. J. Biochem. 43, 377-378.
17. Ferrero R., Rodriguez-Pascual F., Miras-Portugal M. T. and Torres M. (2000) Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J. Neurochem. 75, 2029-2039.
18. Fujishige K., Kotera J. and Omori K. (1999) Striatum- and testis-specific phosphodiesterase PDE10A. Eur. J. Biochem. 266, 1118-1127.
19. Furuyama T., Inagaki S. and Takagi H. (1993) Localizations of α1 and β1 subunits of soluble guanylate cyclase in the rat brain. Brain Res. Mol. Brain Res. 20, 335-344.
20. Garthwaite J. (1985) Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. Br. J. Pharmacol. 85, 297-307.
21. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
22. Garthwaite J. (2000) The physiological roles of nitric oxide in the central nervous system, in Handbook of Experimental Pharmacology, vol. 143 (Mayer B., ed.), pp. 259-275. Springer, Berlin.
23. Garthwaite J. and Garthwaite G. (1987) Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J. Neurochem. 48, 29-39.
24. Gibb B. J. and Garthwaite J. (2001) Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13, 539-544.
25. Greenberg L. H., Troyer E., Ferrendelli J. A. and Weiss B. (1978) Enzymic regulation of the concentration of cyclic GMP in mouse brain. Neuropharmacology 17, 737-745.
26. Griffiths C., Garthwaite J., Goodwin D. A. and Garthwaite J. (2002) Dynamics of nitric oxide during simulated ischaemia-reperfusion in rat striatal slices measured using an intrinsic biosensor, soluble guanylyl cyclase. Eur. J. Neurosci. 15, 962-968.
27. Juilfs D. M., Soderling S., Burns F. and Beavo J. A. (1999) Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev. Physiol. Biochem. Pharmacol. 135, 67-104.
28. Lee Y. C., Martin E. and Murad F. (2000) Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc. Natl Acad. Sci. USA 97, 10763-10768.
29. Lewicki J. A., Brandwein H. J., Mittal C. K., Arnold W. P. and Murad F. (1982) Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside. J. Cyclic Nucleotide Res. 8, 17-25.
30. Manganiello V. C., Taira M., Degerman E. and Belfrage P. (1995) Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell. Signal. 7, 445-455.
31. Markerink-van Ittersum M., Steinbusch H. W. and de Vente J. (1997) Region-specific developmental patterns of atrial natriuretic factor-and nitric oxide-activated guanylyl cyclases in the postnatal frontal rat brain. Neuroscience 78, 571-587.
32. Michie A. M., Lobban M., Muller T., Harnett M. M. and Houslay M. D. (1996) Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Cell. Signal. 8, 97-110.
33. Mullershausen F., Russwurm M., Thompson W. J., Liu L., Koesling D. and Friebe A. (2001) Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J. Cell. Biol. 155, 271-278.
34. Polli J. W. and Kincaid R. L. (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J. Neurosci. 14, 1251-1261.
35. Potter L. R. and Garbers D. L. (1994) Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J. Biol. Chem. 269, 14636-14642.
36. Prast H. and Philippu A. (2001) Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64, 51-68.
37. Reinhardt R. R. and Bondy C. A. (1996) Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain. Neuroscience 72, 567-578.
38. Sasaki T., Kotera J., Yuasa K. and Omori K. (2000) Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 271, 575-583.
39. Schudt D. A., Dent G. and Rabe K. F. (1996a) cGMP-inhibitied phosphodiesterases (PDE-3), in Phosphodiesterase Inhibitors, pp. 89-109. Academic Press, London, UK.
40. Schudt D. A., Dent G. and Rabe K. F. (1996b) Interaction of PDE4 inhibitors with enzymes, in Phosphodiesterase Inhibitors, pp. 110-126. Academic Press, London.
41. Soderling S. H. and Beavo J. A. (2000) Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 12, 174-179.
42. Southam E. and Garthwaite J. (1993) The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32, 1267-1277.
43. van Staveren W. C., Markerink-van Ittersum M., Steinbusch H. W. and de Vente J. (2001) The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res. 888, 275-286.
44. Trabace L. and Kendrick K. M. (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem. 75, 1664-1674.
45. Turko I. V., Ballard S. A., Francis S. H. and Corbin J. D. (1999) Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Mol. Pharmacol. 56, 124-130.
46. Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
47. Yan C., Bentley J. K., Sonnenburg W. K. and Beavo J. A. (1994) Differential expression of the 61 kDa and 63 kDa calmodulindependent phosphodiesterases in the mouse brain. J. Neurosci. 14, 973-984.
48. Yuasa K., Ohgaru T., Asahina M. and Omori K. (2001) Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A) Comparison of rat and human PDE11A splicing variants. Eur. J. Biochem. 268, 4440-4448.